Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?

BACKGROUND/OBJECTIVE: Delays in times to surgery, chemotherapy, and radiotherapy impair survival in breast cancer patients. Neoadjuvant chemotherapy (NAC) confers equivalent survival to adjuvant chemotherapy (AC), but it remains unknown which approach facilitates faster initiation and completion of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Med
Autori principali: Melchior, Nicole M., Sachs, Darren B., Gauvin, Gabrielle, Chang, Cecilia, Wang, Chihsiung E., Sigurdson, Elin R., Daly, John M., Aggon, Allison A., Hayes, Shelly B., Obeid, Elias I., Bleicher, Richard J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Clinical Cancer Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7163083/
https://ncbi.nlm.nih.gov/pubmed/32096915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2912
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi